Insider Transactions in Q1 2024 at Repligen Corp (RGEN)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
Anthony Hunt |
SELL
Bona fide gift
|
Direct |
2,000
-1.08%
|
-
|
|
Mar 18
2024
|
Margaret Pax |
BUY
Grant, award, or other acquisition
|
Direct |
92
+50.0%
|
-
|
|
Mar 11
2024
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
3,517
-12.66%
|
$678,781
$193.73 P/Share
|
|
Mar 11
2024
|
Ralf Kuriyel Senior VP, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
1,271
+4.38%
|
$109,306
$86.1 P/Share
|
|
Mar 08
2024
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
16,707
-1.07%
|
$3,324,693
$199.02 P/Share
|
|
Mar 08
2024
|
Anthony Hunt |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.0%
|
$16
$16.55 P/Share
|
|
Mar 07
2024
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-1.44%
|
$75,270
$195.72 P/Share
|
|
Mar 07
2024
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
2,867
-1.4%
|
$559,065
$195.72 P/Share
|
|
Mar 07
2024
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-1.37%
|
$75,270
$195.72 P/Share
|
|
Mar 07
2024
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,206
-5.42%
|
$235,170
$195.72 P/Share
|
|
Mar 05
2024
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
7,275
-3.43%
|
$1,418,625
$195.52 P/Share
|
|
Mar 05
2024
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22
-0.1%
|
$4,290
$195.52 P/Share
|
|
Mar 04
2024
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
1,111
-0.52%
|
$214,423
$193.99 P/Share
|
|
Mar 04
2024
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
197
-0.88%
|
$38,021
$193.99 P/Share
|
|
Mar 04
2024
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
592
-1.03%
|
$114,256
$193.35 P/Share
|
|
Mar 04
2024
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
135
-0.5%
|
$26,055
$193.99 P/Share
|
|
Mar 01
2024
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50
+0.22%
|
-
|
|
Mar 01
2024
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
453
-1.65%
|
$86,523
$191.79 P/Share
|
|
Mar 01
2024
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
820
-3.53%
|
$156,620
$191.79 P/Share
|
|
Mar 01
2024
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
447
-1.53%
|
$85,377
$191.79 P/Share
|
|
Mar 01
2024
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
3,322
-1.53%
|
$634,502
$191.79 P/Share
|
|
Feb 29
2024
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
404
+1.45%
|
-
|
|
Feb 29
2024
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
404
+1.71%
|
-
|
|
Feb 29
2024
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
391
+1.32%
|
-
|
|
Feb 29
2024
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
2,504
+1.14%
|
-
|
|
Feb 27
2024
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,691
+27.58%
|
-
|
|
Feb 27
2024
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
19,719
+8.44%
|
-
|
|
Feb 27
2024
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
3,520
+11.5%
|
-
|
|
Feb 27
2024
|
Jason K Garland CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,540
+24.0%
|
-
|
|
Feb 27
2024
|
Olivier Loeillot Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,880
+15.43%
|
-
|
|
Feb 27
2024
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
1,000
-1.13%
|
$193,000
$193.35 P/Share
|
|
Feb 27
2024
|
Karen A Dawes |
BUY
Exercise of conversion of derivative security
|
Direct |
4,626
+4.97%
|
$194,292
$42.07 P/Share
|
|
Feb 23
2024
|
James Bylund Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,373
-23.63%
|
$865,854
$198.08 P/Share
|
|
Feb 23
2024
|
James Bylund Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
940
+4.83%
|
$88,360
$94.33 P/Share
|